Home › Cancer (all types) › NCT06923501
Evaluation of a Mobile App Program for Coping With Cancer
Feasibility, Acceptability, and Preliminary Outcomes of a Mobile App for Coping With Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Stated willingness to comply with all study procedures and availability for the duration of the study (8 weeks active intervention and 3-month follow up) * Have a confirmed diagnosis of cancer; or have been treated for cancer within the last two years, including adjuvant therapies * Over the age of 18 * Able to understand and read English * Able to navigate a mobile app with minimal assistance from study staff * Able to provide informed consent Exclusion Criteria: * Are taking part in psychotherapy at any time during the study * Have an un-treated or under-treated mental health disorder based on pre-study screening that may require a referral to individual mental health care.
About the study
The goal of this clinical trial is to learn if a mobile app program for people with a history of cancer can help treat distress. The main questions it aims to answer is:
Do participants use the Tools for Coping with Cancer Calm Health mobile app and do they find it helpful?
Does the Tools for Coping with Cancer Calm Health mobile app improve mood, quality of life, and help with coping?
Participants will be asked to use a 13-session self-management program (Tools for Coping with Cancer) housed within the Calm Health app. Participants will use this app on their own device, in their own home. Participants will have access to the program for 8 weeks and will be asked to work their way through the program at their own pace. Participants will be asked to complete questionnaires about their mood, quality of life, coping, and experience with the app three times: at the start of the study, after 8 weeks using the app, and then 3-months after using the app.
What is being tested
- Tools for Coping with Cancer Calm Health mobile app program (device)
Sponsor: Yale University · Participants: 50 · Started: Jun 11, 2026
Contact the study team
- Gabriel Cartagena, PhD · Phone: 516-855-8539
Official record on ClinicalTrials.gov — NCT06923501
Locations in the U.S.
| Connecticut | Smilow Cancer Hospital, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.